DIN 02229868 — HYOSCINE BUTYLBROMIDE INJECTION 20 MG
HYOSCINE BUTYLBROMIDE INJECTION is a solution of Hyoscine Butylbromide marketed by SANDOZ CANADA INCORPORATED. The full Hyoscine Butylbromide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02229868
- Brand name
- HYOSCINE BUTYLBROMIDE INJECTION
- Active ingredient
- Hyoscine Butylbromide
- Strength
- 20 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
- Manufacturer
- SANDOZ CANADA INCORPORATED
- Health Canada status
- MARKETED
- Drug class
- Antimuscarinic (antispasmodic) agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Hyoscine Butylbromide products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02512335 | ACCEL-HYOSCINE | 10 MG | TABLET | ACCEL PHARMA INC | MARKETED |
| 00363812 | BUSCOPAN | 10 MG | TABLET | SANOFI CONSUMER HEALTH INC | MARKETED |
| 00363839 | BUSCOPAN | 20 MG | SOLUTION | SANOFI CONSUMER HEALTH INC | MARKETED |
| 02508419 | HYOSCINE BUTYLBROMIDE INJECTION BP | 20 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED |